| Structure | Chemical Name | CAS | MF |
|
(7R,7aR,14R,14aS)-Dodecahydro-7,14-methano-4H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine-4-one
|
486-88-4
|
C15H24N2O
|
|
(3R,5'aS)-5-(3-Furanyl)-3',5',5'aβ,7',8',8'aβ-hexahydro-7'β-methylspiro[furan-3(2H),6'-[6H]naphtho[1,8-bc]furan]-2,2'(4'H)-dione
|
66322-19-8
|
C19H18O5
|
|
(3R,3aR,6R,6aR)-3,6-Bis(acetyloxy)-2,3,3a,5,6,6a-hexahydrothieno[3,2-b]thiophene 1,4-dioxide
|
|
C10H14O6S2
|
|
lubiprostone
|
333963-40-9
|
C20H32F2O5
|
|
(1R,3AR,4R,6AR)-3A,6A-DIMETHYLHEXAHYDRO-1H-1,4-METHANOCYCLOPENTA[C]FURAN-1-CARBOXYLIC ACID
|
|
C11H16O3
|
|
(2R)-1-{4-[(1aR,6r,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol
|
167354-41-8
|
C32H31F2N3O2
|
|
(7R,7AR,14R)-DODECAHYDRO-7,14-METHANO-DIPYRIDO[1,2-A:1',2'-E][1,5]DIAZOCINE
|
|
C15H24N2
|
|
((3R,8aS)-hexahydro-1H-pyrrolo[2,1-c][1,4]oxazin-3-yl)MethanaMine
|
1143524-06-4
|
C8H16N2O
|
|
((3R,8aS)-hexahydro-1H-pyrrolo[2,1-c][1,4]oxazin-3-yl)Methyl acetate
|
650577-84-7
|
C10H17NO3
|
|
(1R,3aR,6R,9E,12aS)-3,3a,6,7,8,11,12,12a-Octahydro-3a,6,10-trimethyl-1-isopropylcyclopentacycloundecene-2,4(1H,5H)-dione
|
|
C20H32O2
|
|
(11R,11aS)-2,3,5,6,7,8-Hexahydro-3'-methoxy-4',9-dimethylspiro[1H-cyclopenta[b]pyrrolo[1,2-a]azepine-11(10H),2'(5'H)-furan]-5',10-dione
|
|
|
|
(3R,3aR,4R,6E,9R,10E,11aR)-4,9-Bisacetoxy-3a,4,5,8,9,11a-hexahydro-3,6,10-trimethylcyclodeca[b]furan-2(3H)-one
|
56192-71-3
|
C19H26O6
|
|
|
(1R,7aS)-Hexahydro-1H-pyrrolizine-1α-methanol acetate
|
|
|
|
|
RAR-α (Retinoic acid -R-α)
|
|
|
|
|
rasG protein
|
|
|
|
|
ras-GRF1
|
|
|
|
|
RasGRP3 protein
|
|
|
|
|
ras-GRF2
|
|
|
|
|
RasGRP protein
|
|
|
|
|
RasGRP2 protein
|
|
|
|
|
RAS-GST, AGAROSE
|
|
|
|
|
ras GTPase-Activating Proteins
|
|
|
|
|
rasGTPase-activating protein-1
|
|
|
|
(1R,3aR,4S,7aR)-Octahydro-1-[(1S)-2-iodo-1-methylethyl]-7a-methyl-1H-inden-4-ol
|
116535-65-0
|
C13H23IO
|
|
(1R,10aR)-7-[(S)-2-Acetoxy-2-(3-furyl)ethyl]-6,6aβ,7,8-tetrahydro-5β,8α-dihydroxy-11-methylene-1β,7β-ethanofuro[3,4-i][2]benzopyran-3(5H)-one
|
69749-02-6
|
C22H24O8
|
|
(3R,3'aR,5S,7'aα)-1',4,5,5',6',8',8'aβ,9'aβ-Octahydro-5-(3-furyl)-4'α,9'bα-dihydroxy-6'β-methylspiro[furan-3(2H),7'(4'H)-oxireno[2,3]naphtho[1,8a-c]furan]-1',2(7'aH)-dione
|
54927-89-8
|
C20H22O8
|
|
(1R,3aR,8S,12aR)-1,2,3,3a,4,5,6,7,8,9,10,12a-Dodecahydro-1,8,12-trimethyl-4-methylene-1,11-ethanocyclopentacycloundecene
|
60837-37-8
|
C20H32
|
|
(1R,3aR,8S,12aS,13S)-1,2,3,3a,6,7,8,9,10,12a-Decahydro-1,4,8,12-tetramethyl-1,11-ethanocyclopentacycloundecen-13-ol
|
67517-10-6
|
C20H32O
|
|
(3R,3'aR,5S,6'aβ,10'aR)-4,5,4',5',6',6'a,9',10'-Octahydro-5-(3-furyl)-10'β-hydroxy-8'α-methylspiro[furan-3(2H),7'(8'H)-naphtho[1,8a-c]furan]-2,3'(3'aH)-dione
|
64719-81-9
|
C20H24O6
|
|
(R)-1-((3AR,6S,6AR)-6-(BENZYLOXY)-TETRAHYDRO-2,2-DIMETHYLFURO[2,3-D][1,3]DIOXOL-5-YL)ETHANE-1,2-DIOL
|
|
C16H22O6
|
|
(1R,4aR,6S,8aS)-6,8a-dimethyl-5-methylidene-1,4,4a,6,7,8-hexahydronaphthalene-1,2-dicarbaldehyde
|
128718-14-9
|
C15H20O2
|
|
|
ras Guanine Nucleotide Exchange Factors
|
|
|
|
|
RAS (G12V)-GST-FUSION, HUMAN, AGAROSE CONJUGATE
|
|
|
|
|
Ras(G12V)-GST-Fusion,Hu, Conj
|
|
|
|
(1R,10aR)-7-[(S)-2-(3-Furyl)-2-hydroxyethyl]-6,6aβ,7,8-tetrahydro-5β,8α-dihydroxy-11-methylene-1β,7β-ethanofuro[3,4-i][2]benzopyran-3(5H)-one
|
66302-50-9
|
C20H22O7
|
|
|
(2R,8aR)-2-[(4R,8R)-4,8,12-Trimethyltridecyl]-3,4-dihydro-2,5,7,8-tetramethyl-8aβ-[[(S)-1-cyano-1,3-dimethylbutyl]peroxy]-2H-1-benzopyran-6(8aH)-one
|
|
|
|
|
(2R,8aR)-2-[(4R,8R)-4,8,12-Trimethyltridecyl]-3,4,4a,5-tetrahydro-4aα,5α-epoxy-8aα-ethoxy-2H-1-benzopyran-6(8aH)-one
|
|
|
|
|
(2R,8aR)-2-[(4R,8R)-4,8,12-Trimethyltridecyl]-3,4-dihydro-2,5,7,8-tetramethyl-8aβ-[[(R)-1-cyano-1,3-dimethylbutyl]peroxy]-2H-1-benzopyran-6(8aH)-one
|
|
|
|
(3R,3a'R,4R,6'S,6a'S)-6'-Acetyloxy-2',2'-dimethyl-4-[[(4-methylphenyl)sulfonyl]oxy]tetrahydrospiro[furan-3(2H),5'(3'aH)-furo[2,3-d][1,3]dioxol]-2-one
|
62746-89-8
|
C19H22O10S
|
|
(2R,4aR,5'R,6S,7R,8R,8aS)-4,4a,6,7,8,8a-Hexahydro-5'-methyl-6-methoxy-2-phenyl-7-[2-[tert-butyldimethylsilyloxy]ethyl]-3'-(trimethylsilyloxy)spiro[pyrano[3,2-d]-1,3-dioxin-8,1'-cyclopentan]-2'-ene
|
|
C30H50O6Si2
|
|
|
Ras,Hu,Recomb,CVLL Type
|
|
|
|
|
RAS, HUMAN FULL LENGTH
|
|
|
|
|
Ras,Hu,Recomb,Wild-Type
|
|
|
|
|
(R)-Artabotriol
|
|
C5H10O3
|
|
RAS INHIBITORY PEPTIDE
|
159088-48-9
|
C53H91N19O11
|
|
|
Ras-interacting protein 3
|
|
|
|
|
Ras interaction interference protein 1
|
|
|
|
|
(11R,11aS)-11-Hydroxy-1,2,3,10,11,11aβ-hexahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one
|
|
|
|
(6R,12ar)-1,2,3,4-Tetrahydro-2-Chloroethyl-1-(3,4-Methylenedioxyphenyl)-9H-Pyrido[3,4-B]Indole-3-Carboxylic Methyl Ester
|
|
C22H21ClN2O4
|
|
[(1R,8aS)-7-(2-hydroxypropan-2-yl)-1,8a-dimethyl-6-oxo-1,2,3,4-tetrahydronaphthalen-2-yl] (Z)-2-methylbut-2-enoate
|
|
C20H28O4
|
|
(7R,9AR)-TERT-BUTYL 7-(AMINOMETHYL)HEXAHYDRO-1H-PYRIDO[1,2-A]PYRAZINE-2(6H)-CARBOXYLATE
|
373646-56-1
|
C14H27N3O2
|
|
(2R,11AS)-2-HYDROXY-1,2,3,11A-TETRAHYDRO-10H-PYRROLO[2,1-C][1,4]-BENZODIAZEPINE-5,11-DIONE
|
182823-26-3
|
C12H12N2O3
|
|
|
RASI-1 protein
|
|
|
|
(2R,4aR,7S,8R,8aR)-Hexahydro-7,8-dihydroxy-2-phenyl-5H-1,3-dioxino[5,4-b]pyridine-5-carboxylic Acid PhenylMethyl Ester
|
138381-83-6
|
C21H23NO6
|
|
[(7R,7aR,12S,14S,14aS)-Dodecahydro-4-oxo-7,14-methano-4H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocin]-12-ium-12-olate
|
|
C15H24N2O2
|
|
(3R,8AS)-3-ISOPROPYL-7-DIMETHYL-8A-METHYL BICYCLIC LACTAM
|
|
C13H23NO2
|
|
(3R,7AS)-3-ISOPROPYL-7A-PHENYL BICYCLIC LACTAM
|
|
C15H19NO2
|
|
(1R,4AS)-7-ISOPROPYL-1,4A-DIMETHYL-1,2,3,4,4A,9,10,10A-OCTAHYDROPHENANTHRENE-1-CARBOXYLIC ACID
|
|
C20H28O2
|
|
(+)-(3R,4aR,5S,6S,6aS,10S,10aR,10bS)-Dodecahydro-5,6,10,10b-tetrahydroxy-3,4a,7,7,10a-pentamethyl-3-vinyl-1H-naphtho[2,1-b]pyran-1-one 5-acetate 6-ester with N,N-dimethyl-β-alanine
|
113462-26-3
|
C27H43NO8
|
|
|
RARTLSFAEPG
|
|
|
|
|
RAT ADIPOCYTE MARATHON-READY CDNA
|
|
|
|
|
Rat Adiponectin
|
|
|
|
|
RAT ADRENAL LYSATE
|
|
|
|
(2R)-2-[(4aR)-5,6,8-Tris(acetyloxy)-1,2,3,4,4a,9-hexahydro-10-hydroxy-1,1,4a-trimethyl-9-oxophenanthren-7-yl]-1-propanol 1-acetate
|
75379-00-9
|
|
|
(3R,12aR)-3,6α,9β-Trimethyl-3β,12α-epoxy-3,4,5,5aα,6,7,8,8aα,9,10-decahydro-10α-ethoxypyrano[4,3-j]-1,2-benzodioxepin
|
82534-75-6
|
C17H28O5
|
|
|
(3R,12aR)-3,6α,9β-Trimethyl-10-propoxy-3β,12α-epoxy-3,4,5,5aα,6,7,8,8aα,9,10-decahydropyrano[4,3-j]-1,2-benzodioxepin
|
|
|
|
|
rat airway mucin 7s
|
|
|
|
|
RATALBUMIN,TEXASRED
|
|
|
|
|
RATALBUMIN,RABBITANTI-,FITC
|
|
|
|
|
RATALBUMIN,RABBITANTI-
|
|
|
|
|
RATALBUMIN,FITC
|
|
|
|
|
RATALBUMIN,RABBITANTI-,TEXASRED
|
|
|
|
|
RATALLERGEN
|
|
|
|
|
RATB-CELL,PAN,PLASMACELL,CLONE:KI-B1R,MABANTI-
|
|
|
|
|
RAT BCL-2-RELATED OVARIAN KILLER AA41-61
|
|
|
|
R-(-)-Arundic Acid Acyl-β-D-Glucuronide
|
|
C17H30O8
|
|
R-(-)-Arundic Acid-d3
|
1246816-50-1
|
C11H22O2
|
|
|
RAT ANTI-MOUSE B7-1 FITC
|
|
|
|
|
RAT ANTI-MOUSE V-BETA 7 TCR R-PE
|
|
|
|
|
RAT ANTI-MOUSE IL-5 FITC
|
|
|
|
|
Anti-CD86 antibody
|
|
|
|
|
RAT ANTI-MOUSE V-BETA 12B TCR FITC
|
|
|
|
|
RAT ANTI-MOUSE C-KIT BIOTIN
|
|
|
|
|
RAT ANTI-HUMAN IGE BIOTIN CONJUGATED
|
|
|
|
|
RAT ANTI-MOUSE IFN-ALPHA R-PE
|
|
|
|
|
RAT ANTI-MOUSE CD8B BIOTIN
|
|
|
|
|
RAT ANTI-HUMAN IGD HRP CONJUGATED
|
|
|
|
|
RAT ANTI-MOUSE PAN NK-CELLS R-PE
|
|
|
|
|
RAT ANTI-MOUSE B7-1 BIOTIN
|
|
|
|
|
RAT ANTI-MOUSE V-ALPHA 8 TCR FITC
|
|
|
|
|
RAT ANTI-MOUSE IL-4 FITC
|
|
|
|
|
RAT ANTI-MOUSE V-BETA 7 TCR FITC
|
|
|
|
|
RAT ANTI-MOUSE BETA2 INTEGRIN R-PE
|
|
|
|
|
RAT ANTI-MOUSE CD2 BIOTIN
|
|
|
|
|
RAT ANTI-MOUSE IL-2 BIOTIN
|
|
|
|
|
RAT ANTI-MOUSE CD38 FITC
|
|
|
|
|
Rat Anti Mouse Interleukin-12p75
|
|
|
|
|
RAT ANTI-MOUSE CD24 FITC
|
|
|
|
|
RAT ANTI-MOUSE IFN-GAMMA FITC
|
|
|
|
|
RAT ANTI-MOUSE GR-1 TRI-COLOR(R) (R-PE-CY5 TANDEM)
|
|
|